James Sapirstein's extensive pharmaceutical career spans over three decades, with a focus on HIV therapeutics. His leadership at AzurRx BioPharma and involvement in numerous drug launches underscore his industry expertise.
biopharma · biotech
James Sapirstein's extensive pharmaceutical career spans over three decades, with a focus on HIV therapeutics. His leadership at AzurRx BioPharma and involvement in numerous drug launches underscore his industry expertise.
Key Points:
Serves as President and CEO of AzurRx BioPharma (AZRX: NASDAQ) Boasts over 35 years of experience in the pharmaceutical industry Participated in nearly two dozen drug product launches Played key roles in several HIV product launches Contributed to introducing new classes of HIV therapeutics
Why It Matters: Sapirstein's wealth of experience and leadership in pharmaceutical innovation directly impacts the development of life-saving medications.
Read more:
← All Global Trial Accelerators editions · Contact bioaccess®